Fluoroscopy-Guided vs. Ultrasound-Guided Transfemoral Access in Complex PCI: Results of the ULTRACOLOR Study

During complex percutaneous coronary interventions (PCI), it is common to use large-caliber guidewire catheters to provide greater support. Large-caliber transradial access has proven to be viable and safe in such procedures. However, a small radial artery, severe spasm, or variant anatomy are contraindications for this access, making transfemoral access a better choice in these cases.

¿Deberíamos adoptar el uso rutinario del ultrasonido para guiar el acceso femoral?

The use of ultrasound-guided puncture for transfemoral access has been shown to reduce vascular complications, but its use is not a routine procedure. In the recent UNIVERSAL clinical trial, ultrasound-guided transfemoral puncture did not result in a significant reduction in bleeding or vascular complications compared to fluoroscopy-guided access.

 It is worth noting that one of the limitations of this trial was the low proportion of complex PCI cases and that most of the accesses used were 6 Fr. It is currently unclear whether there is any benefit in using ultrasound to guide transfemoral access in the case of large-caliber catheters (>7 Fr).

The objective of this multicenter randomized study was to demonstrate the superiority of ultrasound over fluoroscopy in complex PCI, specifically in terms of bleeding and/or vascular complications (BARC 2, 3, 5) that require intervention during hospitalization.

Lea también: Tratamiento borde a borde en la válvula tricuspídea: evolución a un año.

The primary endpoint (PE) was defined as clinically relevant bleeding at the access site or a vascular complication that required intervention during hospitalization. The secondary endpoint (SE) covered safety and efficacy aspects, including BARC 2, 3, or 5 bleeding at the transfemoral access site at 30 days of follow-up, BARC 2, 3, or 5 bleeding at secondary femoral or radial artery sites, major adverse cardiovascular events (MACE) at 30 days, vascular complications that did not require intervention, procedure time, access time, and success rate at the first puncture.

The study included a total of 544 patients, of whom 274 were randomized to the ultrasound-guided group and 270 to the fluoroscopy-guided group. The mean age was 71 years, and 76% of the subjects were men. The most frequent indication for complex PCI was stable angina, and 68% of patients required PCI for chronic total occlusion. The PE occurred in 18.9% of the fluoroscopy-guided group, compared with 15.7% of the ultrasound-guided group (p=0.32). 

The success rate for the first puncture was 92% for the ultrasound-guided group, compared with 85% for the fluoroscopy-guided group (p=0.02). The median catheterization lab time was 102 minutes for the ultrasound group and 105 minutes for the fluoroscopy group (p=0.43), while the MACE rate at one month was 4.1% for the fluoroscopy group and 2.6% for the ultrasound-guided access group (p=0.32).

Conclusión 

Routine use of ultrasound to guide transfemoral puncture in complex PCI did not significantly reduce clinically relevant bleeding or vascular complications compared with fluoroscopy, although it did improve first puncture success.

Original Title: Ultrasound-guided versus fluoroscopy-guided large-bore femoral access in PCI of complex coronary lesions: the international, multicentre, randomised ULTRACOLOR Trial.

Reference: Thomas A. Meijers , MD et al EuroIntervention 2024;20:e876-e886.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

Más artículos de este Autor

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Artículos relacionados

Jornadas SOLACIspot_img

Artículos recientes

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...